Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Italy Physician Groups Market

ID: MRFR/MED/50834-HCR
200 Pages
Satyendra Maurya
Last Updated: February 06, 2026

Italy Physician Groups Market Research Report: Size, Share, Trend Analysis By Types of Physician Groups (Independent Physician Groups, Hospital-Affiliated Physician Groups, Multispecialty Physician Groups, Single Specialty Physician Groups), By Service Offered (Primary Care Services, Specialty Care Services, Emergency Care Services, Preventive Care Services), By Practice Size (Small Practices, Medium Practices, Large Practices) and By Payer Mix (Public Payers, Private Insurers, Self-Pay) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Italy Physician Groups Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Specialty (USD Billion)
  49.     4.1.1 Cardiology
  50.     4.1.2 Dermatology
  51.     4.1.3 Pediatrics
  52.     4.1.4 Orthopedics
  53.     4.1.5 Oncology
  54.   4.2 Healthcare, BY Practice Type (USD Billion)
  55.     4.2.1 Solo Practice
  56.     4.2.2 Group Practice
  57.     4.2.3 Hospital Affiliated
  58.     4.2.4 Multi-Specialty
  59.     4.2.5 Urgent Care
  60.   4.3 Healthcare, BY Patient Demographics (USD Billion)
  61.     4.3.1 Pediatric
  62.     4.3.2 Adult
  63.     4.3.3 Geriatric
  64.     4.3.4 Women
  65.     4.3.5 Men
  66.   4.4 Healthcare, BY Service Delivery Model (USD Billion)
  67.     4.4.1 In-Person
  68.     4.4.2 Telemedicine
  69.     4.4.3 Home Healthcare
  70.     4.4.4 Mobile Clinics
  71.     4.4.5 Integrated Care
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Healthcare
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Humanitas (IT)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 San Donato Group (IT)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 GVM Care & Research (IT)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Fatebenefratelli (IT)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 Istituto Clinico Città di Brescia (IT)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Policlinico di Milano (IT)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 Casa di Cura Privata del Policlinico (IT)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Ospedale San Raffaele (IT)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 ITALY MARKET ANALYSIS BY SPECIALTY
  142.   6.3 ITALY MARKET ANALYSIS BY PRACTICE TYPE
  143.   6.4 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  144.   6.5 ITALY MARKET ANALYSIS BY SERVICE DELIVERY MODEL
  145.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  146.   6.7 RESEARCH PROCESS OF MRFR
  147.   6.8 DRO ANALYSIS OF HEALTHCARE
  148.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  149.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  150.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  151.   6.12 HEALTHCARE, BY SPECIALTY, 2024 (% SHARE)
  152.   6.13 HEALTHCARE, BY SPECIALTY, 2024 TO 2035 (USD Billion)
  153.   6.14 HEALTHCARE, BY PRACTICE TYPE, 2024 (% SHARE)
  154.   6.15 HEALTHCARE, BY PRACTICE TYPE, 2024 TO 2035 (USD Billion)
  155.   6.16 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
  156.   6.17 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
  157.   6.18 HEALTHCARE, BY SERVICE DELIVERY MODEL, 2024 (% SHARE)
  158.   6.19 HEALTHCARE, BY SERVICE DELIVERY MODEL, 2024 TO 2035 (USD Billion)
  159.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  160. 7 LIST OF TABLES
  161.   7.1 LIST OF ASSUMPTIONS
  162.     7.1.1
  163.   7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  164.     7.2.1 BY SPECIALTY, 2026-2035 (USD Billion)
  165.     7.2.2 BY PRACTICE TYPE, 2026-2035 (USD Billion)
  166.     7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Billion)
  167.     7.2.4 BY SERVICE DELIVERY MODEL, 2026-2035 (USD Billion)
  168.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  169.     7.3.1
  170.   7.4 ACQUISITION/PARTNERSHIP
  171.     7.4.1

Italy Healthcare Market Segmentation

Healthcare By Specialty (USD Billion, 2026-2035)

  • Cardiology
  • Dermatology
  • Pediatrics
  • Orthopedics
  • Oncology

Healthcare By Practice Type (USD Billion, 2026-2035)

  • Solo Practice
  • Group Practice
  • Hospital Affiliated
  • Multi-Specialty
  • Urgent Care

Healthcare By Patient Demographics (USD Billion, 2026-2035)

  • Pediatric
  • Adult
  • Geriatric
  • Women
  • Men

Healthcare By Service Delivery Model (USD Billion, 2026-2035)

  • In-Person
  • Telemedicine
  • Home Healthcare
  • Mobile Clinics
  • Integrated Care

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions